Equivalence of SYN008 versus omalizumab in patients with refractory chronic spontaneous urticaria: A multicenter, randomized, double-blind, parallel-group, active-controlled phase III study
SYN008 与奥马珠单抗治疗难治性慢性自发性荨麻疹患者的等效性：一项多中心、随机、双盲、平行组、活性对照的 III 期研究
期刊:Chinese Medical Journal
影响因子:7.3
doi:10.1097/CM9.0000000000003593
Li, Jingyi; Liang, Yunsheng; Feng, Wenli; Deng, Liehua; Fang, Hong; Ji, Chao; Lin, Youkun; Zhang, Furen; Xia, Rushan; Zhang, Chunlei; Guo, Shuping; Lin, Mao; Li, Yanling; Zhang, Shoumin; Kang, Xiaojing; Chen, Liuqing; Song, Zhiqiang; Yao, Xu; Li, Chengxin; Han, Xiuping; Guo, Guoxiang; Guo, Qing; Duan, Xinsuo; Li, Jie; Su, Juan; Li, Shanshan; Sun, Qing; Tao, Juan; Ding, Yangfeng; Deng, Danqi; Li, Fuqiu; Suo, Haiyun; Wu, Shunquan; Qiu, Jingbo; Luo, Hongmei; Li, Linfeng; Li, Ruoyu
